» Articles » PMID: 30755588

LncRNA MIAT Sponges MiR-149-5p to Inhibit Efferocytosis in Advanced Atherosclerosis Through CD47 Upregulation

Overview
Journal Cell Death Dis
Date 2019 Feb 14
PMID 30755588
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerotic cardio-cerebrovascular disease and death remain the leading cause of morbidity and mortality worldwide. Defective efferocytosis, the clearance of apoptotic cells by macrophages, is thought to lead to increased inflammation and necrotic core formation in atherosclerotic lesions. However, very little is known about the role of long noncoding RNA (lncRNA) during this process. Here we show that lncRNA myocardial infarction associated transcript (MIAT) was markedly elevated in the serum of patients with symptoms of vulnerable atherosclerotic plaque and the macrophages of necrotic cores in an advanced atherosclerosis mouse model. MIAT knockdown attenuated atherosclerosis progression, reduced necrotic core size, and increased plaque stability in vivo. Furthermore, MIAT knockdown promoted clearance of apoptotic cells by macrophages in vivo and in vitro. Mechanistic studies revealed that MIAT acted as a micro RNA (miRNA) sponge to positively modulate the expression of anti-phagocytic molecule CD47 through sponging miR-149-5p. Together, these findings identified a macrophage MIAT/miR-149-5p /CD47 pathway as a key factor in the development of necrotic atherosclerotic plaques.

Citing Articles

The role of long non-coding RNAs in cardiovascular diseases: A comprehensive review.

Xie X, Huang M, Ma S, Xin Q, Wang Y, Hu L Noncoding RNA Res. 2025; 11:158-187.

PMID: 39896344 PMC: 11783329. DOI: 10.1016/j.ncrna.2024.12.009.


The functions of immune system-derived miRNAs in cardiovascular diseases.

Sufianov A, Agaverdiev M, Mashkin A, Ilyasova T Noncoding RNA Res. 2024; 11:91-103.

PMID: 39736852 PMC: 11683256. DOI: 10.1016/j.ncrna.2024.11.004.


Smooth muscle cell-specific CD47 deletion suppresses atherosclerosis.

Pervaiz N, Mehmood R, Aithabathula R, Kathuria I, Ahn W, Le B Life Sci. 2024; 361():123315.

PMID: 39675550 PMC: 11740882. DOI: 10.1016/j.lfs.2024.123315.


Efferocytosis: the resolution of inflammation in cardiovascular and cerebrovascular disease.

Zhang B, Zou Y, Yuan Z, Jiang K, Zhang Z, Chen S Front Immunol. 2024; 15:1485222.

PMID: 39660125 PMC: 11628373. DOI: 10.3389/fimmu.2024.1485222.


Engineered macrophages: an "Intelligent Repair" cellular machine for heart injury.

Zhang Z, Du H, Gao W, Zhang D Cell Regen. 2024; 13(1):25.

PMID: 39592532 PMC: 11599506. DOI: 10.1186/s13619-024-00209-7.


References
1.
Tay Y, Rinn J, Pandolfi P . The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505(7483):344-52. PMC: 4113481. DOI: 10.1038/nature12986. View

2.
Doran A, Ozcan L, Cai B, Zheng Z, Fredman G, Rymond C . CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis. J Clin Invest. 2017; 127(11):4075-4089. PMC: 5663361. DOI: 10.1172/JCI94735. View

3.
Proto J, Doran A, Gusarova G, Yurdagul Jr A, Sozen E, Subramanian M . Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution. Immunity. 2018; 49(4):666-677.e6. PMC: 6192849. DOI: 10.1016/j.immuni.2018.07.015. View

4.
Matlung H, Szilagyi K, Barclay N, van den Berg T . The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer. Immunol Rev. 2017; 276(1):145-164. DOI: 10.1111/imr.12527. View

5.
Henson P . Cell Removal: Efferocytosis. Annu Rev Cell Dev Biol. 2017; 33:127-144. DOI: 10.1146/annurev-cellbio-111315-125315. View